These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33497027)

  • 61. Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease.
    Michalska-Jakubus M; Kowal-Bielecka O; Chodorowska G; Bielecki M; Krasowska D
    Rheumatology (Oxford); 2011 Apr; 50(4):746-55. PubMed ID: 21149250
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
    Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
    BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
    Gao L; Skinner J; Nath T; Lin Q; Griffiths M; Damico RL; Pauciulo MW; Nichols WC; Hassoun PM; Everett AD; Johns RA
    Respir Res; 2024 Jun; 25(1):235. PubMed ID: 38844967
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
    Colalillo A; Grimaldi MC; Vaiarello V; Pellicano C; Leodori G; Gigante A; Romaniello A; Rosato E
    Rheumatology (Oxford); 2022 May; 61(6):2450-2456. PubMed ID: 34605890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combined peripheral and central ultrasound for the diagnosis of PAH-SSc patients.
    Correale M; Rotondo C; Bevere EML; Tricarico L; Rella V; Villani D; Granato M; Migliozzi C; Cantatore FP; Brunetti ND; Corrado A
    Echocardiography; 2024 Jun; 41(6):e15853. PubMed ID: 38853623
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis.
    Rice LM; Mantero JC; Stratton EA; Warburton R; Roberts K; Hill N; Simms RW; Domsic R; Farber HW; Layfatis R
    Arthritis Res Ther; 2018 Aug; 20(1):185. PubMed ID: 30115106
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
    J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pulmonary arterial hypertension associated with connective tissue diseases].
    Legendre P; Mouthon L
    Presse Med; 2014 Sep; 43(9):957-69. PubMed ID: 25129118
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension.
    Gluschke H; Siegert E; Minich WB; Hackler J; Riemekasten G; Kuebler WM; Simmons S; Schomburg L
    Front Immunol; 2022; 13():935787. PubMed ID: 35860272
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tie2 as a novel key factor of microangiopathy in systemic sclerosis.
    Moritz F; Schniering J; Distler JHW; Gay RE; Gay S; Distler O; Maurer B
    Arthritis Res Ther; 2017 May; 19(1):105. PubMed ID: 28545512
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Single nucleotide polymorphisms of the HIF1A gene are associated with susceptibility to pulmonary arterial hypertension in systemic sclerosis and contribute to SSc-PAH disease severity.
    Takagi K; Kawamoto M; Higuchi T; Tochimoto A; Harigai M; Kawaguchi Y
    Int J Rheum Dis; 2020 May; 23(5):674-680. PubMed ID: 32144871
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in France.
    Hachulla E; Launay D; Boucly A; Mouthon L; de Groote P; Cottin V; Pugnet G; Prévôt G; Bourlier D; Dauphin C; Chaouat A; Weatherald J; Simonneau G; Montani D; Humbert M; Sitbon O; Giovannelli J
    Chest; 2020 Apr; 157(4):945-954. PubMed ID: 31756332
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.
    Pasarikovski CR; Granton JT; Roos AM; Sadeghi S; Kron AT; Thenganatt J; Moric J; Chau C; Johnson SR
    Arthritis Res Ther; 2016 Jan; 18():30. PubMed ID: 26819137
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort.
    Bauer Y; de Bernard S; Hickey P; Ballard K; Cruz J; Cornelisse P; Chadha-Boreham H; Distler O; Rosenberg D; Doelberg M; Roux S; Nayler O; Lawrie A
    Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33334933
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
    Fairley JL; Hansen D; Ross L; Proudman S; Sahhar J; Ngian GS; Walker J; Host LV; Morrisroe K; Apostolopoulous D; Ferdowsi N; Wilson M; Tabesh M; Stevens W; Nikpour M;
    Arthritis Res Ther; 2023 May; 25(1):77. PubMed ID: 37173780
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Sun Q; Hackler J; Hilger J; Gluschke H; Muric A; Simmons S; Schomburg L; Siegert E
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32630589
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study.
    Iribarren C; Phelps BH; Darbinian JA; McCluskey ER; Quesenberry CP; Hytopoulos E; Vogelman JH; Orentreich N
    BMC Cardiovasc Disord; 2011 Jun; 11():31. PubMed ID: 21672190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.